Profil
Henry Rath worked as an Executive Director of Corporate Development at Amgen, Inc. from 2003 to 2012.
He also worked as a Senior Vice President of Business Development at Seres Therapeutics, Inc. and as a Senior Manager of Strategy and Business Development at Baxter BioScience Corp.
In addition, he was a Vice President of Business Development at Astria Therapeutics, Inc. and a Member of the Biotechnology Group at The Lek.
He was also a Member at Oppenheimer & Co., Inc. Mr. Rath holds an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from Harvard College.
He is currently working as the Chief Business Officer at Surface Oncology, Inc.
Tidigare kända positioner av Henry Rath
| Företag | Position | Slut |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Företagsledare/Principal | 2023-09-08 |
| AMGEN INC. | Företagsledare/Principal | 2012-05-01 |
| SERES THERAPEUTICS, INC. | Företagsledare/Principal | - |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Företagsledare/Principal | - |
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Företagsledare/Principal | - |
Henry Raths utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surface Oncology, Inc.
Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
















